상품명칭 |
Lopinavir 대사 산물 M-1 |
별명 |
(aS)-N-[(1S,3S,4S)-4-[[(2,6-디메틸페녹시)아세틸]아미노]-3-하이드록시-5-페닐-1-(페닐메틸)펜틸]테트라하이드로-A-(1-메틸에틸)-2,4-디옥소-1(2H)-피리미딘아세트아미-d; (aS)-N-[(1S,3S,4S)-4-[[(2,6-디메틸페녹시)아세틸]아미노]-3-히드록시-5-페닐-1-(페닐메틸)펜틸]테트라하이드로-α-(1-메틸에틸)-2,4-디옥소-1(2H)-피리미딘아세트아미-드; (aS)-N-[(1S,3S,4S)-4-[[(2,6-디메틸페녹시)아세틸]아미노]-3-하이드록시-5-페닐-1-(페닐메틸)펜틸]테트라하이드로-A-(1-메틸에틸)-2,4-디옥소-1(2H)-피리미딘아세트아미-드 |
영문 이름 |
Lopinavir Metabolite M-1;(aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- d; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de |
분자식 |
C37H46N4O6 |
분자량 |
642.7843 |
InChI |
InChI=1/C37H46N4O6/c1-24(2)34(41-19-18-32(43)40-37(41)46)36(45)38-29(20-27-14-7-5-8-15-27)22-31(42)30(21-28-16-9-6-10-17-28)39-33(44)23-47-35-25(3)12-11-13-26(35)4/h5-17,24,29-31,34,42H,18-23H2,1-4H3,(H,38,45)(H,39,44)(H,40,43,46)/t29?,30?,31-,34-/m0/s1 |
cas번호 |
192725-39-6 |
분자 구조 |
|
굴절 지수 |
1.582 |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|